Table 5 Unadjusted and adjusted mean change in clinical outcome measures from baseline at 3-months
Change in outcome measures | RGwo-mHealth (n = 32) Mean (95% CI) | RGw-mHealth (n = 32) Mean (95% CI) | CG (n = 32) Mean (95% CI) | p |
|---|---|---|---|---|
∆ WOMAC pain (0–20) | ||||
Unadjusted | 1.35 (0.45, 2.25) | 2.75 (2.43, 3.06) | 0.28 (0.01, 0.54) | < 0.001 |
Adjusted | 1.47 (0.93, 2.01) | 2.54 (1.99, 3.09) | 0.37 (− 0.16, 0.90) | < 0.001 |
∆ TUG score (seconds) | ||||
Unadjusted | 1.14 (0.86, 1.43) | 2.98 (2.29, 3.68) | 0.14 (− 0.02, 0.32) | < 0.001 |
Adjusted | 1.34 (0.97, 1.70) | 2.64 (2.26, 3.02) | 0.29 (− 0.06, 0.65) | < 0.001 |
∆ Katz ADL score (0–6) | ||||
Unadjusted | − 0.46 (− 0.75, − 0.17) | − 1.25 (− 1.65, − 0.84) | − 0.12 (− 0.32, 0.07) | < 0.001 |
Adjusted | − 0.51 (− 0.73, − 0.29) | − 1.13 (− 1.36, − 0.91) | − 0.12 (0.41, 0.03) | < 0.001 |
∆ PSFS (0–10) |  |  |  |  |
Unadjusted | − 1.00 (− 1.18, − 0.82) | − 2.65 (− 2.88, − 2.43) | − 0.05 (− 0.14, 0.02) | < 0.001 |
Adjusted | − 1.00 (− 1.17, − 0.83) | − 2.65 (− 2.82, − 2.48) | − 0.06 (− 0.22, 0.10) | < 0.001 |